Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
10/05/2010
Trade Name:
Aridol Powder for Inhalation
Generic Name or Proper Name (*):
mannitol
Indications Studied:
Assessment of bronchial hyperresponsiveness in patients without clinically apparent asthma
Label Changes Summary:
* New indication in patients 6 years and older* Efficacy assessed in a total of 246 children and adolescents 6 to 17 years in 2 clinical trials* Bronchial challenge testing should not be performed in children < 6 years due to their inability to provide reliable spirometric measurements * Adverse events similar to adults* Information on adverse events and clinical studies* New indication, dosage form, and route of administration
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Pharmaxis
NNPS:
FALSE
Therapeutic Category:
Diagnostic aid
-
-